Nature Reviews Drug Discovery 10, 341-349 (May 2011) | doi:10.1038/nrd3445
The Committee for Orphan Medicinal Products and the European Medicines Agency. Scientific Secretariat 1
Keywords: orphan medicinal products, European Union, rare conditions, orphan drug designations, Committee for Orphan Medicinal Products (COMP), marketing authorization in Europe.
